Metronidazol Vioser

Metronidazole, the active ingredient in Metronidazol Vioser, is a nitroimidazole antibiotic presented as an intravenous solution for injection use. It treats a range of anaerobic bacterial and protozoal infections in adult and paediatric patients as prescribed by a qualified health professional.

GNH USA supplies Metronidazol Vioser as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metronidazole is used to treat infections caused by anaerobic bacteria and certain protozoa. - Anaerobic bacterial infections: eradicates susceptible anaerobes and reduces infection severity. - Bacterial vaginosis: restores normal vaginal flora by eliminating over‑growth of anaerobic bacteria. - Trichomoniasis: eliminates Trichomonas vaginalis, relieving symptoms and preventing transmission. - Amoebic dysentery: destroys Entamoeba histolytica trophozoites, controlling intestinal disease. - Clostridioides difficile infection: suppresses toxin‑producing C. difficile, aiding clinical recovery.

Metronidazole may cause a range of adverse reactions, most of which are dose‑related and reversible upon discontinuation.

Common Side Effects: - Nausea: mild to moderate upset stomach. - Metallic taste: transient metallic sensation in the mouth. - Headache: mild to moderate headache episodes. - Diarrhoea: loose stools during therapy.

Serious or Rare Side Effects: - Seizures: rare neurologic events requiring immediate medical attention. - Peripheral neuropathy: tingling or numbness in extremities. - Severe allergic reactions: anaphylaxis or angioedema. - Stevens‑Johnson syndrome: severe skin and mucous membrane reaction. - Hepatic toxicity: elevated liver enzymes or jaundice. - Neutropenia: marked reduction in white blood cells.

Metronidazole requires careful monitoring in specific clinical situations. - Renal function assessment: adjust therapy in patients with impaired kidney function. - Hepatic monitoring: use cautiously in liver disease and watch for elevated enzymes. - Alcohol avoidance: advise patients to abstain from alcohol during and 48 hours after treatment. - Allergic reaction vigilance: discontinue if signs of hypersensitivity appear. - Pregnancy and lactation: prescribe only when benefits outweigh potential risks. - Store at ambient temperature: keep in original container, protect from moisture and light.

Metronidazole can interact with several medicines, altering efficacy or safety.

Major Interactions (Avoid): - Disulfiram‑like reaction with alcohol: severe flushing, tachycardia, hypotension. - Warfarin: increased anticoagulant effect, monitor INR closely. - Lithium: elevated lithium levels, risk of toxicity.

Moderate Interactions (Monitor Closely): - Cimetidine: may increase metronidazole plasma concentrations. - Phenytoin: may reduce metronidazole levels, monitor therapeutic response.